An interventional study of Total Hip Arthoplasty in Total Hip Arthroplasty, sponsored by Rothman Institute Orthopaedics. Status unknown at 2 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2013-04-09.
Sponsored by Rothman Institute Orthopaedics · Not applicable and Interventional
This study aims to investigate short-term outcomes following the use of two femoral stems used during Total Hip arthoplasty: the Fitmore Femoral stem and the M/L Taper Femoral stem.
Rothman Institute Orthopaedics is the lead sponsor of 118 studies on the registry; 17 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Procedure: Total Hip Arthoplasty
Procedure: Total Hip Arthoplasty
Short term hip function
Early functional outcome will be measured using the modified Harris Hip score at the first post-operative visit
Time frame: within six weeks post-operative
Short-Term Pain Levels of direct anterior and anterolateral surgical approaches
Short-term (6 weeks post-op) pain will also be compared between the approach used for the total hip replacement: namely direct anterior and anterolateral using a VAS pain scale
This study is status unknown, as verified in Apr 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Rothman Institute Orthopaedics